Basic information

CPKB ID CP00514
IUPAC Name
(3S,6R,10R,13E,16S)-10-[(3-chloro-4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-[(1S)-1-[(2R,3R)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone
Synonyms
Source

Nostoc [Division : Bacteria]

Taxonomy :1177 (Unassigned-Cyanobacteriota-Nostocales-Cyanophyceae-Nostocaceae Unassigned)  

Wikipedia: Nostoc

PubChem  

Function

Anti-Cancer   PubChem  

Information

Cryptophycin 1 is a natural product found in Nostoc with data available. Curacomycin is a homodetic cyclic peptide found in several Streptomyces species, consisting of 3-hydroxyasparagine, L-ornithine, L-isoleucine, D-leucine, D-valine and 5-chloro-L-tryptophan joined in sequence in a cyclic arrangement by peptide linkages. It exhibits antibacterial properties. It has a role as a bacterial metabolite and an antibacterial agent. It is a homodetic cyclic peptide and a chloroindole.

PubChem|6438401  

Legend

Structure

similarity structure
Molecular Formula

C35H43CLN2O8

Molecular Weight 654.270794 g/mol
SMILES

RUN SEA Predictions

COc1ccc(C[C@H]2NC(=O)C=CC[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)[C@H](C)CNC2=O)cc1Cl  

PubChem|6438401

InChI
InChI=1S/C35H43ClN2O8/c1-20(2)16-29-35(42)44-27(22(4)31-32(46-31)24-10-7-6-8-11-24)12-9-13-30(39)38-26(33(40)37-19-21(3)34(41)45-29)18-23-14-15-28(43-5)25(36)17-23/h6-11,13-15,17,20-22,26-27,29,31-32H,12,16,18-19H2,1-5H3,(H,37,40)(H,38,39)/b13-9+/t21-,22+,26-,27+,29+,31-,32-/m1/s1  
InChIKey
PSNOPSMXOBPNNV-SEYVRMDENA-N
2D Structure
PubChem|6438401
3D Structure
PubChem|6438401

Sequence

Graph alignment
IUPAC Condensed
cyclo[OLeu-Unk-D-Phe(3-Cl,4-OMe)-bAib(R)]  

PubChem|6438401

Amino acid chain
OLeu(1)--Unk--D-Phe(3-Cl,4-OMe)--bAib(R)(1)  

CyclicPepedia|PP

Graph representation
OLeu,Unk,D-Phe(3-Cl,4-OMe),bAib(R) @0,3  

CyclicPepedia|PP

One letter code from Structure
Y  

CyclicPepedia|Struct2seq

Amino acid chain from Structure
NMe-OMe-TyrC  

CyclicPepedia|Struct2seq

Description of the conversion sequence The one letter code and Amino acid chain derived from the structural transformation may be inconsistent, with the Amino acid chain containing Essential Amino acid and the one letter code not.

Chemical and Physical Properties

Structure Properties

Property Name Property Value
Exact Mass 654.270794
Number of Rings 4.0
Complexity 1.0
XlogP3 AA 4.734
Heavy Atom Count 46.0
Hydrogen Bond Donor Count 2.0
Hydrogen Bond Acceptor Count 8.0
Rotatable Bond Count 8.0
Property Name Property Value
Formal Charge 0.0
Refractivity 172.0044
Rule_of_Five 0.0
Number of Atoms 46.0
Topological Polar Surface Area 132.56
Refractivity 172.0044
Veber Rule 1.0
Ghose Filter 0.0

Property Name Property Value
RDKit Fingerprint
11100110100010110100110111110001001001111111110010101011100101110111001110111101100110010011110111010101110101001111001101111010001001001011101011001110000011110111101010100110110111001110000110110110011011101000110111000111011001110111000111101101111101101111011110001001100001000001111100000111100111010010100011011101100100111011111111101110001011100001111001101011110000000011001001100011010011100110000100001100001010010000101110011111111110101100001010111111111011011001010000111110001110000110110001001100110000101110110010100111110011101101101110011110001110111111110110101100110110011100111101110101101010111111111100001001101001111110100010001111110001000111101010101001000101001100011011111000100111000010011001010010000011111101110110011010011111010110111110011010001001010010011010111001001110001101100100111111111110110100111011101010010000111001011111011011111100011100001001111001001111101011100101010111011101110111000101111110001011111110010110011010111100001111011001010001110100111000001010111101101111100110110010101001111001101111110011111010111111101101010011011111101110101101011101011010000110111000001011000011100010010101101001111001111111100000100111111001111011011011111101001111010001101101010110100110011011110111011111110011101101110010000100010001111010010001111101111001111011100111000111101111100101101011111010011101000111110101111010110110100101101010111110100101101111011110000101111101100110101010000001111001100101011111101101011110101010110000010101111001101101001010101111110011000100110100000001010010011010110110000011111110100110110100000111111110101000101011000110101001001100100001110011010011100100110110010001000001110101010110110110010100010110011111011010001100001101000111000110111000100100001011011011010100010011010110101010110110100001111111000010001110101001101110101000010010011111110111101011100011100001000110110011010101100001011111011100001100011111110011010100110011101000110111110001010101111010011011011010011111001011101101110110001011001011010110101101000100110101111111111001010011
Morgan Fingerprint
0100000100100100000000000000000001000000000000000000000000000000100000000001000010000010001000100000000010000000000100100000000000000000000000000000000000000000000000000000000100000000000000000000000000000000000000000000000000000000000000000000000001000001000000000000000000000000001101000010000000000100000000100010000000000000000000010000000000000000000010000000001000000000000000000000010000001000000000000000000000000000001000000000000000000000000000000010000000000010000000000000000000000000000000000000000010000000000000000000000000000000000100000000000011000000000000010000000000000000010000100000000000000000000000000000000000000001000000000010000010010000010000000000000000100000000000110000000000000000000000000000001000100000000000000000001000000010000000000000000000000100000010010000000000010000000010000000000100000000010000000110000001000001000000000001000000010000000000000000000001000000000000000000000000000010100000000000010000100010000001000000000000000000100000010000000000000000000100000000000000011100
MACCS Keys
00000000000000001000001000000000000000000000000000000010010000100000000010100001001000010111110101011001100100110101110011010111100110101100111111100111111111111111110

Binding Target

Other evidence

Property Name Property ID
TTD D0LI3C
DrugMAP DM73C4K

Manufacturers

Manufacturers Name Value
CreativePeptides
Bayer healthcare pharmaceuticals
Upsher smith laboratories
Merck
Manufacturers Name Value
Apotex
Baxter Healthcare Corp
Pharmasources
Novartis
AstraZeneca

Information Source

Reference

Pubmed_ID Title DOI Journal

17786911

Numerical characterization of the conformation of cyclic peptides and its application 10.1002/jcc.20744.

J Comput Chem

Numerical characterization of the conformation of cyclic peptides and its application

Abstract

  • Many classes of functional cyclic peptide molecules are determined by experimental techniques, but few similarities of cyclic peptides are detectable. We propose three numerical characterizations of conformations of cyclic peptides. By incorporating the information on atomic coordinates of cyclic peptides, the coordinates are transformed into a characteristic sequence. Then we calculate its center of gravity, the eigenvalues of its Euclidean and L/L matrices, and regard them as descriptors to numerically characterize the conformations of cyclic peptides. Finally, the method is tested by analyzing the similarities of cyclic peptides presented in Table 1.

8824953

Estrogen-like activity of cyclic peptides from Vaccaria segetalis extracts 10.1055/s-2006-959373.

Planta Med

Estrogen-like activity of cyclic peptides from Vaccaria segetalis extracts

Abstract

  • Methanol and ethyl acetate extracts of Wang Bu Liu Xing (seeds of Vaccaria segetalis, Caryophyllaceae) and cyclic peptides (named segetalins A and B) obtained from the extracts were shown to have an estrogen-like activity.

9113340

Thionation of segetalins A and B, cyclic peptides with estrogen-like activity from seeds of Vaccaria segetalis 10.1016/s0968-0896(97)00001-1.

Bioorg Med Chem

Thionation of segetalins A and B, cyclic peptides with estrogen-like activity from seeds of Vaccaria segetalis

Abstract

  • Thionation of estrogen-like active cyclic peptides, segetalins A (1) and B (2), with Lawesson's reagent provided each two thiosegetalins; thiosegetalin A1 Gly-1-psi(CS-NH)-Val-2; Trp-5-psi (CS-NH)-Ala-6segetalin A, thiosegetalin A2 Gly-1-psi(CS-NH)-Val-2; Ala-6-psi(CS-NH)-Gly-1segetalin A, thiosegetalin B1 Gly-1-psi (CS-NH)-Val-2; Ala-3-psi(CS-NH)-Trp-4segetalin B, and thiosegetalin B2 Gly-1-psi(CS-NH)-Val-2; Trp-4-psi(CS-NH)-Ala-1segetalin B. Thiosegetalin A2 only showed estrogen-like activity against ovariectomized rats. On the basis of their conformations analysed by NMR experiments, the backbone conformation was considered to play an important role in estrogen-like activity for segetalins."